Doramectin

Producers shown on SFDA

(Record date:22/10/2021）

Producers shown on EP

Not showing any

Producer:Livzon New North River Pharmaceutical Co., Ltd., established in 1990, covers an area of 150000 square meters and a construction area of 50000 square meters. It mainly produces pharmaceutical raw materials and pharmaceutical intermediates. Its products are widely used in cardio cerebrovascular, organ transplantation, anti infection, hypoglycemic and other drugs.

New North River Pharmaceutical has a perfect quality assurance system. Two varieties have passed the on-site inspection of FDA, seven varieties have obtained the DMF number of the United States, one product has obtained the EU CEP certificate, and all API production lines have passed the domestic GMP certification.

Staff size:600-699 people

Registered capital:RMB 239 million 887 thousand and 700 

Producer:Hubei Honch Pharmaceutical Co., Ltd. was established in 2007, covering an area of 20000 square meters. The company focuses on the R & D and production of innovative antitumor and high-end veterinary drug APIs. Over the years, Hongzhong has passed the on-site audit of FDA for many times. Many products have obtained domestic GMP certification, many products have obtained EU CEP certificate, and many products have been successfully registered in Japan, India, Russia and other countries.

Hubei Honch Pharmaceutical Co., Ltd.

Staff size:100-199 people

Registered capital:RMB 34.666 million

Producer:Jiangsu Willing Bio-Tech Co., Ltd. , founded in 2011, is a wholly-owned subsidiary of Jiangsu Lingyun Pharmaceutical Co., Ltd. the company covers an area of 202.5 mu, about 135000 square meters, with a total investment of 500 million yuan and fixed assets of 40 million yuan. The company has passed the inspection of FDA and has China GMP certification

Staff size:100-199 persons
Registered capital:RMB 180 million

Producer:Zhejiang Hisun Pharmaceutical Co.,Ltd., founded in 1956, is one of the largest production bases of antibiotics and antitumor drugs in China.

Headquartered in Taizhou, the company has established integrated pharmaceutical bases in Taizhou, Zhejiang, Fuyang, Hangzhou and Rudong, Jiangsu. The research, development and production of drug treatment fields cover anti-tumor, anti infection, cardiovascular, endocrine, immunosuppression, antidepressant, orthopedics, etc. The company has more than 40 varieties officially certified by FDA of the United States, EDQM of the European Union, TGA of Australia and KFDA of Korea.

Staff size:About 8500 people

Registered capital:RMB 1 billion 196 million

Producer:Shandong Qifa Pharmaceutical Co., Ltd. is a biopharmaceutical base invested by Qilu Pharmaceutical Co., Ltd. in 1987, mainly producing microbial drugs. The company covers an area of about 200000 square meters and produces more than 8000 tons of microbial drugs per year.

The company's main products have passed FDA, EDQM and APVMA certification.

Staff size:600-699 persons

Registered capital:RMB 73.33062 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978